Oramed Pharmaceuticals Inc. (ORMP)
$4.82+0.21%Close
BUYRECOVERY · day 16
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $197M
- Avg volume
- 259.2K
- Beta
- 1.16
- Div yield
- 5.19%
- P/E (TTM)
- 1.14
- Short % float
- 2.64%
- Days to cover
- 5.7
- SI change
- +9.2%
- 1W
- +5.47%
- 1M
- +19.60%
- 3M
- +20.80%
- YTD
- +65.64%
- vs SPY 1W
- +6.66%
- vs SPY 1M
- +16.28%
- vs SPY 3M
- +18.41%
- vs SPY YTD
- +53.88%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- BVSBUYBioventus Inc.BULLQ 1$14.02-2.50%
- ACADBUYACADIA Pharmaceuticals Inc.BULLQ 19$29.65+0.51%
- HCSGSELLHealthcare Services Group, Inc.RECOVERYQ 15$22.80+0.13%
- FMSSELLFresenius Medical Care AG & Co. KGaARECOVERYQ 9$23.53+0.43%
- SYKSELLStryker CorporationRECOVERYQ 24$327.81-0.50%
- AZNSELLAstraZeneca PLCRECOVERYQ 15$166.71+0.44%
- MGTXBUYMeiraGTx Holdings plcBULLQ 9$14.83+3.42%
- VMDSELLViemed Healthcare, Inc.CRISISQ 23$9.09+2.71%
- ELVBUYElevance Health Inc.RECOVERYQ 15$402.63+0.52%
- ADUSBUYAddus HomeCare CorporationBULLQ 19$120.82+0.01%
- HQYBUYHealthEquity, Inc.BULLQ 17$105.40-0.01%
- INMDSELLInMode Ltd.BULLQ 16$15.10+0.27%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 36
- VALUE
- 45
- GROWTH
- 47
- GARP
- 9
- TYPE
- Dividend Compounder
Composite of Value · Growth · GARP
ROIC43.8%
REV YoY-
ROE73.0%
EPS YoY-
ROA55.3%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM1.14
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B0.62
P/FCF-
EV/EBITDA1.09
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.23
ALTMAN Z-
CURR RATIO4.98
ND/EBITDA-
BETA1.16
